Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

President Donald Trump’s approval rating declined one point in a Reuters/Ipsos poll released Tuesday—hours after Trump claimed he has the “highest poll numbers [he’s] ever had”—keeping his rating ...